Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michele Ly, Daniela Molena, Smita Sihag, Abraham Jing-Ching Wu, Pari M. Shah, Ping Gu, Ryan Sugarman, Steven Brad Maron, Sree Bhavani Chalasani, Marina Shcherba, Randy Yeh, Laura H. Tang, Carly Alterman, Paige Collins, Kendall Cowie, Yelena Yuriy Janjigian, David H. Ilson, Geoffrey Yuyat Ku
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4229622674